期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Atorvastatin protects against cerebral ischemia/ reperfusion injury through anti-inflammatory and antioxidant effects 被引量:29
1
作者 Qiuyun Tu Hui Cao +2 位作者 Wei Zhong Binrong Ding Xiangqi Tang 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第3期268-275,共8页
In addition to its lipid-lowering effect, atorvastatin exerts anti-inflammatory and antioxidant effects as well. In this study, we hypothesized that atorvastatin could protect against cerebral isch-emia/reperfusion in... In addition to its lipid-lowering effect, atorvastatin exerts anti-inflammatory and antioxidant effects as well. In this study, we hypothesized that atorvastatin could protect against cerebral isch-emia/reperfusion injury. The middle cerebral artery ischemia/reperfusion model was established, and atorvastatin, 6.5 mg/kg, was administered by gavage. We found that, after cerebral ischemia/ reperfusion injury, levels of the inflammation-related factors E-selectin and myeloperoxidase were upregulated, the oxidative stress-related marker malondialdehyde was increased, and super- oxide dismutase activity was decreased in the ischemic cerebral cortex. Atorvastatin pretreatment significantly inhibited these changes. Our findings indicate that atorvastatin protects against ce-rebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects. 展开更多
关键词 nerve regeneration brain injury cerebral ischemia/reperfusion ATORVASTATIN E-SELECTIN MYELOPEROXIDASE superoxide dismutase MALONDIALDEHYDE inflammation free radicals blood-brainbarrier stroke NSFC grant neural regeneration
下载PDF
A mix & act liposomes of phospholipase A2-phosphatidylserine for acute brain detoxification by blood‒brain barrier selective-opening
2
作者 Zinan Zhang Wenbin Cao +8 位作者 Huanchun Xing Shuai Guo Lijuan Huang Lin Wang Xin Sui Kui Lu Yuan Luo Yongan Wang Jun Yang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第4期1827-1844,共18页
In the treatment of central nervous system disease,the blood-brain barrier(BBB)is a major obstruction to drug delivery that must be overcome.In this study,we propose a brain-targeted delivery strat-egy based on select... In the treatment of central nervous system disease,the blood-brain barrier(BBB)is a major obstruction to drug delivery that must be overcome.In this study,we propose a brain-targeted delivery strat-egy based on selective opening of the BBB.This strategy allows some simple bare nanoparticles to enter the brain when mixed with special opening material;however,the BBB still maintains the ability to completely block molecules from passing through.Based on the screening of BBB opening and matrix delivery mate-rials,we determined that phospholipase A2-catalyzed 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine li-posomes can efficiently carry drugs into the brain immediately.At an effective dose,this delivery system is safe,especially with its effect on the BBB being reversible.This mix&act delivery system has a simple structure and rapid preparation,making it a strong potential candidate for drug delivery across the BBB. 展开更多
关键词 Liposomes Phospholipase A2 PHOSPHOSERINE blood-brainbarrier Selectively open Mix&act
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部